Jane Chung - Chief Executive Officer, Director at SUTRO BIOPHARMA, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Jane Chung in SUTRO BIOPHARMA, INC.

Buys

Open market
Shares
+12,500
Avg price
$0.8009
Total value
+$10,011

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+12,500
Share %
100%
Total value
+$10,011

Reported holdings for Jane Chung in SUTRO BIOPHARMA, INC.

Form 4 holding Chief Executive Officer, Director

SUTRO BIOPHARMA, INC.

Security class
Restricted Stock Units (RSUs)
Shares / value
0
Estimated value
$421,600
Report date
04 Mar 2026
Price
$1.36
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

SUTRO BIOPHARMA, INC.

Security class
Restricted Stock Unit (RSU)
Shares / value
5,000
Estimated value
$12,521
Report date
12 Dec 2025
Price
$1.59
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

SUTRO BIOPHARMA, INC.

Security class
Stock Option (right to buy)
Shares / value
175,000
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jane Chung in SUTRO BIOPHARMA, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .